- CABA Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Cabaletta Bio (CABA) 8-K1 Feb 24Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of MyositisFinancial data
Company Profile